Sigma-Aldrich Q4 Revenues Increase 3 Percent Despite Negative Currency Effects | GenomeWeb

NEW YORK (GenomeWeb) – Sigma-Aldrich today reported a 3 percent year-over-year increase in its fourth quarter sales. 

For the three months ended Dec. 31, 2014, the firm posted $705 million in sales, up from $684 million a year ago, beating the average analysts' estimate of $694.6 million. Organically, sales were up 7 percent year over year. Currency effects reduced sales by 5 percent, while acquisitions and divestitures increased sales by 1 percent, the St. Louis-based firm said. 

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: metagenomic-based technique for determining protein structure, and more.

An academic laments the rise of narcissism in the sciences, the Guardian reports.

Outgoing FDA commissioner Robert Califf writes in an editorial that the agency can help boost innovation.

The Trump transition team has asked NIH Director Francis Collins to remain at his post, though it's unclear for how long that will be.